Sheela Foam Limited (SFL)
Analysts/Institutional Investor Meet/Con. Call Updates
AI summary
- Q2FY27 consolidated revenue grew 19% to INR1,045 Cr; PAT rose 5x to INR46 Cr
- H1FY27 revenue up 22% to INR2,077 Cr; PAT increased over 6x to INR109 Cr
- Furlenco became subsidiary Oct 1, FY27 revenue INR229 Cr, EBITDA INR89 Cr (39% margin)
- Mattress segment H1 grew 11%, Foam 26%; Australia and Spain businesses profitable
- Raw material inflation impacted margins; consolidated EBITDA margin ~9.6% in H1FY27
- Expect combined FY27 revenue ~INR5,000 Cr and EBITDA ~INR600 Cr (12%+ margin)
- Price increases passed to market; volume growth soft due to affordability constraints
- Marketing spend increased to support demand; festive season shifted from Q2 to Q3
- Multiple analyst queries on margin outlook; management expects 12%+ margin if raw material prices normalize
- Net debt expected ~INR800 Cr post Furlenco consolidation; free cash flow to reduce debt
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 SFL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add SFL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Sheela Foam Limited
Important.
The summary above is generated automatically from Sheela Foam Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.